Andrew D. Goodman, M.D., FAAN, President
Dr. Goodman is Professor of Neurology, Chief of the Neuroimmunology Unit, and Director of the Multiple Sclerosis Center at the University of Rochester in Rochester, NY. His interests include clinical and experimental therapeutics research. He has been a lead investigator (or a member of the steering committee) for various national and international clinical trials of new therapies for multiple sclerosis.
Dr. Goodman is a past Chair of the Multiple Sclerosis Section of the AAN. He has served the National Multiple Sclerosis Society in a variety of capacities including Co-Chair of the National Long-term Care Committee, member of the National Client Education Committee, and member of the Executive Committee of the National Clinical Advisory Board. He is a graduate of Rutgers University and the Rutgers New Jersey Medical School. He served as a resident in internal medicine and neurology at Mt. Sinai Medical Center in New York City and as a Medical Staff Fellow in the Neuroimmunology Branch at the National Institutes of Health intramural program in Bethesda, Maryland.
Elliott G. Gross, M.D., FAAN, Treasurer
Joshua M. Cohen, M.D., M.P.H.
Joshua M. Cohen, MD, MPH is Director of Education at Mount Sinai Continuum Hospitals, Director of the Headache Fellowship Program at the Headache Institute and Adolescent Headache Center, an attending neurologist at Mount Sinai Roosevelt Hospital, and an assistant professor of neurology at the Icahn School of Medicine at Mount Sinai. He is Board certified in Neurology and Headache Medicine. He is a leader in organized medicine on the national, state, and local level, currently serving as President of the New York County Medical Society and on the governing Council of the Medical Society of the State of New York (MSSNY).
He has also worked extensively with non-profits dedicated to improving public health. Since 2013, he has served on the Board of Directors of the American Medical Association Foundation . He was a founding Board member of the Nan Lightstone Foundation whose mission is to support research and public education on infectious diseases and is former Co-chair of The Trevor Project NextGen, supporting that organization’s work to provide suicide prevention and crisis intervention services to LGBTQ youth.
Dr. Cohen completed his undergraduate training at Harvard University, medical school at the New York University School of Medicine, and his neurology residency at Columbia University’s Neurological Institute. He also trained at the Columbia Mailman School of Public Health where he received his Masters of Public Health. He completed his headache fellowship at The Headache Institute and a mini-fellowship in pediatric headache at Cincinnati Children’s Hospital. He is the recipient of multiple awards and accolades, including the American Headache Society (AHS)/Merck US Human Health Scholarship Award, the Arnold P. Gold Foundation Humanism and Excellence in Teaching Award, and the Harvard University Derek Bok Center Teaching Award.
John A. Ferro, M.D., M.S.Ed.
Dr. John A. Ferro is a clinical neurologist currently practicing with the Rockland Neurological Associates in West Nyack, New York. He is an Attending Neurologist at Nyack Hospital and the Director of the Stroke Center at Nyack Hospital. He is also the Vice Chairman of the General Neurology Section of the American Academy of Neurology.
Dr. Ferro received his B.S. from Fairfield University and his M.D. from Albert Einstein College of Medicine. Dr. Ferro received residency training at Cornell/New York Hospital and fellowship training at Cornell-Hospital for Special Surgery in neurophysiology/EMG. He also has a M.S. in Education from Iona College.
Dr Ferro has worked in a variety of positions during his career including in a multi-specialty practice, as a neurohospitalist, as a solo practitioner, and currently in a single specialty group of six neurologists.
Mill Etienne, M.D.
Robert C. Griggs, M.D., FAAN
Dr. Griggs is Professor of Neurology, Medicine, Pathology and Laboratory Medicine, Pediatrics and the Center for Human Experimental Therapeutics at the University of Rochester School of Medicine and Dentistry. He was Chair of the Department of Neurology and Neurologist-in-Chief at Strong Memorial Hospital (1986-2008). He received his B.A. from the University of Delaware and his M.D. from the University of Pennsylvania. He received training in Internal Medicine at Case Western Reserve University and the University of Rochester where he was Chief Resident in Medicine and Fellow in Immunology. He trained in Neurology at the National Institute of Neurological Disorders and Stroke (NINDS) and the University of Rochester where he was Chief Resident in Neurology.
Dr. Griggs is an internist/neurologist specializing in neuromuscular diseases with a focus on experimental therapeutics. He has directed an NIH-funded training program in the Experimental Therapeutics of Neurological Disease since 1989. This program has trained over 70 clinical neuroscientists who are in academic and other leadership positions around the world. He has published over 350 scientific papers and 26 texts which span the fields of medicine and neurology. He served as Editor-in-Chief of Neurology (1997-2007). He is an Editor of Cecil Textbook of Medicine and of Cecil Essentials of Medicine. He was elected to the Institute of Medicine of the National Academy of Sciences in 1998. He was Editor-in-Chief of Neurology (1996-2006) and President (2009-2011) of the American Academy of Neurology. Since 1998, Dr. Griggs has chaired the Executive Committee of the Muscle Study Group, an international consortium of investigators focused on developing new treatments for neuromuscular disease. Dr. Griggs is the principal investigator or co-principal investigator of federally-funded clinical trials in Duchenne muscular dystrophy, periodic paralysis.
Michael Gruenthal, M.D.
Lindsey Lair, M.D.
Lindsey Lee Lair, MD is a Global Director of Medical Affairs at Merck. Dr. Lair is a board certified neurologist and autonomic specialist and has been a member of the New York State Neurological Society since 2008. She is a Clinical Assistant Professor of Neurology at New York Medical College where she teaches biomedical ethics. Dr. Lair is a member of the American Academy of Neurology (AAN), American Autonomic Society (AAS), and the American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). She was a founding member of the AAN BrainPAC and has been active in advocacy with the AAN through Neurology on the Hill and the Palatucci Advocacy Leadership Forum where she participated as both a member and subsequently as an adviser.
Allan B. Perel, M.D.
Dr. Allan B. Perel is a neurologist on Staten Island, New York. Dr. Perel completed his neurology training at the Columbia Presbyterian Neurological Institute. He is presently the director of the Department of Neurology at Richmond University Medical Center on Staten Island. He is also the medical director of the Comprehensive Multiple Sclerosis Center of Staten Island. Dr. Perel is the medical director of the American Parkinson’s Disease Information and Referral Center of Brooklyn and Staten Island.
Dr. Perel has been practicing neurology for 24 years. He is the president and founder of Alpha Neurology, P.C., his private practice Neurology Group with five other neurologists.
Matthew S. Robbins, M.D.
Matthew S. Robbins, M.D is a neurologist and headache specialist who is an Associate Professor of Clinical Neurology at Albert Einstein College of Medicine, Chief of Neurology at the Weiler Division of Montefiore Medical Center, and Director of Inpatient Services for the Montefiore Headache Center. For the neurology residency he is Associate Program Director and directs the residency research program.
Kirk Roberts, M.D.
Gil I. Wolfe, M.D.
Dr. Gil I. Wolfe is Professor and Chair of the Department of Neurology at University at Buffalo School of Medicine and Biomedical Sciences, SUNY, where he serves as the Irvin and Rosemary Smith Endowed Chair. Prior to January 2012, Dr. Wolfe was Professor of Neurology at the University of Texas (UT) Southwestern Medical School in Dallas. In September 2004, he was named as the Dr. Bob and Jean Smith Foundation Distinguished Chair in Neuromuscular Disease Research. He served as Co-Director of the Muscular Dystrophy Association Clinics and Director of the Myasthenia Gravis and Peripheral Neuropathy Clinics at UT Southwestern. He was also the Clinical Vice Chair for the department.
Dr. Wolfe completed his undergraduate studies at Princeton University and attended medical school at UT Southwestern. He completed an internal medicine internship and trained as a neurology resident and neuromuscular/electromyography fellow at the University of Pennsylvania Medical Center in Philadelphia. He is certified by the American Board of Psychiatry and Neurology in neurology, neuromuscular medicine, and clinical neurophysiology.
Dr. Wolfe is the immediate past chair of the Medical/Scientific Advisory Board (MSAB) for the Myasthenia Gravis Foundation of America (MGFA). His main research interests include idiopathic and immune-mediated peripheral neuropathies and myasthenia gravis. He co-directs the MDA Clinic and also directs intraoperative monitoring for the Univ. at Buffalo Dept. of Neurology. He has authored or co-authored over 100 papers and 20 chapters on neuromuscular disorders. His research has been sponsored by the National Institutes of Health/National Institute of Neurological Disorders and Stroke, Muscular Dystrophy Association, MGFA, and Food and Drug Administration. He is actively involved in the training of younger physicians. He was director of the neuromuscular medicine and clinical neurophysiology fellowships and the neurology residency training program at UT Southwestern. He has received excellence in residency teaching awards on several occasions both at UT Southwestern and Univ. at Buffalo. He serves on the medical advisory boards for the MGFA, Charcot-Marie-Tooth Association, GBS-CIDP Foundation International and Neuropathy Association and has been elected to Fellow of the American Academy of Neurology and the American Neurological Association.